Perfil
Christopher Tapper currently works at Microbiotica Ltd., as Director from 2020, Exvastat Ltd., as Director from 2020, and Cambridge Innovation Capital Ltd, as Principal.
Mr. Tapper received his undergraduate degree in 2014 from the University of Cambridge.
Cargos activos de Christopher Tapper
| Empresas | Cargo | Inicio |
|---|---|---|
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital seeks investment opportunities in companies located in the United Kingdom. The firm focuses on technology and life science companies. It participates in seed, early and late stage capital transactions. The firm makes co-investments. | Inversor de Capital Privado | - |
Exvastat Ltd.
Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Operates as a preclinical-stage pharmaceutical company which develops a treatment for acute respiratory distress syndrome | Director/Miembro de la Junta | 01/08/2020 |
Microbiotica Ltd.
Microbiotica Ltd. BiotechnologyHealth Technology Operates research and experimental development on biotechnology | Director/Miembro de la Junta | 01/09/2020 |
Formación de Christopher Tapper.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
University of Cambridge
University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Cambridge Innovation Capital Ltd
Cambridge Innovation Capital Ltd Investment ManagersFinance Cambridge Innovation Capital seeks investment opportunities in companies located in the United Kingdom. The firm focuses on technology and life science companies. It participates in seed, early and late stage capital transactions. The firm makes co-investments. | Finance |
Microbiotica Ltd.
Microbiotica Ltd. BiotechnologyHealth Technology Operates research and experimental development on biotechnology | Health Technology |
Exvastat Ltd.
Exvastat Ltd. Pharmaceuticals: MajorHealth Technology Operates as a preclinical-stage pharmaceutical company which develops a treatment for acute respiratory distress syndrome | Health Technology |
- Bolsa de valores
- Insiders
- Christopher Tapper
















